.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Farmers Insurance
Johnson and Johnson
Chubb
Colorcon
Deloitte
Teva
Novartis
UBS

Generated: September 24, 2017

DrugPatentWatch Database Preview

Hospira Inc Company Profile

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has seventy-nine approved drugs.

There are four tentative approvals on HOSPIRA INC drugs.

Summary for Applicant: Hospira Inc

Patents:0
Tradenames:60
Ingredients:49
NDAs:79
Drug Master File Entries: (click here to view)31
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
AMPICILLIN AND SULBACTAM
ampicillin sodium; sulbactam sodium
INJECTABLE;INJECTION090653-002Dec 21, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
INDOMETHACIN SODIUM
indomethacin sodium
INJECTABLE;INJECTION204118-001Apr 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
CEFEPIME HYDROCHLORIDE
cefepime hydrochloride
INJECTABLE;INJECTION065369-002Jun 18, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019008-002Apr 29, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION022234-007Jan 24, 2017RXYesNo► Subscribe► Subscribe► Subscribe
Hospira Inc
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION090571-003Aug 31, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION022234-001Mar 8, 2011APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira Inc
LEVETIRACETAM
levetiracetam
INJECTABLE;IV (INFUSION)202869-001Apr 6, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
MORPHINE SULFATE
morphine sulfate
INJECTABLE;INJECTION202515-005Nov 14, 2011DISCNYesNo► Subscribe► Subscribe► Subscribe
Hospira Inc
CEFAZOLIN SODIUM
cefazolin sodium
INJECTABLE;INJECTION065226-001Apr 21, 2005APRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc
NIPENT
pentostatin
INJECTABLE;INJECTION020122-001Oct 11, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for HOSPIRA INC drugs

Drugname Dosage Strength Tradename Submissiondate
argatroban in sodium chloride
Injection1 mg/mL, 50 mL vials
ARGATROBAN
12/16/2011
argatroban
Injection100 mg/mL, 2.5 mL vials
ARGATROBAN
9/24/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Chubb
Teva
Accenture
Cantor Fitzgerald
Deloitte
Argus Health
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot